Transgenic Animals
Transgenic Animals
批准号:
7468592
负责人:
MATTHEW P FROSCH
金额:
$13.49万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-30 至 2013-08-31
关键词:
AddressAdultAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAnimal HousingAnimal HusbandryAnimal ModelAnimalsBiochemicalBiochemistryBiologyBrainBreedingCollaborationsCommercial SourcesCultured CellsDepositionDevelopmentDiseaseEmbryoEnsureExonsFundingGenerationsHistologyHumanIndividualInstitutionInsuranceInvestigationKnowledgeLaboratoriesLinkModelingMusNeuroanatomyNeurodegenerative DisordersNeurologicNeuronsNumbersPathologicPharmacologyProteinsPurposeResearch PersonnelResourcesRoleSourceSystemTg2576TimeTissuesTransgenic AnimalsTransgenic MiceTransgenic ModelTransgenic OrganismsTransportationWorkagedanimal resourcebasecostdesignexperiencehuman diseasemembermouse modelmutantpresenilinprogramsresearch studystructural biologytissue culturetissue preparation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This Core will maintain existing lines of transgenic (and other) mice and will provide animals of various
ages (from embryos to aged adults) to projects within this program.
The Core is organized with two dominant Specific Aims:
¿ Maintaining transgenic mice relevant to the study of presenilin biology and Alzheimer disease and to
provide animals of various ages (from embryos to aged adults) to investigators.
¿ Organizing and coordinating animal requirements across the individual projects to make maximal and
efficient usage of this important, expensive and limited resource.
Animals to be covered in this Core include locally generated mice expressing mutant (M146L) or wild
type forms of human PS1, wild type human APLP2, as well as animals generated in other laboratories.
The later include several transgenic models in which A_ deposition occurs as the consequence of a
mutant form of APP (with or without mutant forms of PS1). These lines include the Tg2576 line of mice
[over-expression of APP-Sw alone], the APPswe/PS1dE9 line of mice [with over-expression of both APPSw
and the exon 9 deleted form of PS1] and the J20 line of mice [over-expression of APP-Sw,Ind ].
The Core will also work with investigators of the Program Project to develop new lines of mice relevant to
their projects should these become relevant. Thus a potential third Specific Aim of the Core is to:
¿ Participate, in collaboration with the relevant investigator(s), in developing and characterizing and
utilizing new mouse models.
By consolidation of efforts involving animals, the Program Project seeks efficient use of animal resources,
through the coordination of requests from different investigators and sharing of the animals when
possible. This will help to keep animal numbers and costs are kept as low as possible while ensuring
that, within the limits of colony space, the needs of investigators in all projects are met. Animals from this
Core are also made available, as possible, to investigators outside of the Program Project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuropathology Core
-
批准号:10378617
-
项目类别:
-
资助金额:$40.41万
-
财政年份:2019
-
负责人:MATTHEW P FROSCH
-
依托单位:
Neuropathology Core
-
批准号:10620678
-
项目类别:
-
资助金额:$35.37万
-
财政年份:2019
-
负责人:MATTHEW P FROSCH
-
依托单位:
Core D - Neuropathology Core
-
批准号:8676353
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2014
-
负责人:MATTHEW P FROSCH
-
依托单位:
TRANSGENIC AND KNOCKOUT ANIMAL CORE
-
批准号:7483177
-
项目类别:
-
资助金额:$35.81万
-
财政年份:2007
-
负责人:MATTHEW P FROSCH
-
依托单位:
Spatial and temporal progression of amyloid angiopathy
-
批准号:6789393
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2002
-
负责人:MATTHEW P FROSCH
-
依托单位:
Spatial and temporal progression of amyloid angiopathy
-
批准号:6934575
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2002
-
负责人:MATTHEW P FROSCH
-
依托单位:
Spatial and Temporal Progression of Amyloid Angiopathy
-
批准号:7844849
-
项目类别:
-
资助金额:$41.8万
-
财政年份:2002
-
负责人:MATTHEW P FROSCH
-
依托单位:
Spatial and Temporal Progression of Amyloid Angiopathy
-
批准号:7477778
-
项目类别:
-
资助金额:$39.8万
-
财政年份:2002
-
负责人:MATTHEW P FROSCH
-
依托单位:
Spatial and Temporal Progression of Amyloid Angiopathy
-
批准号:7320383
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2002
-
负责人:MATTHEW P FROSCH
-
依托单位:
Spatial and Temporal Progression of Amyloid Angiopathy
-
批准号:7617178
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2002
-
负责人:MATTHEW P FROSCH
-
依托单位:
Core--Neuropathology of Parkinson's disease and related Lewy body disorders
-
批准号:6499889
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2001
-
负责人:MATTHEW P FROSCH
-
依托单位:
Core--Neuropathology of Parkinson's disease and related Lewy body disorders
-
批准号:6354788
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2000
-
负责人:MATTHEW P FROSCH
-
依托单位:
CORE--TRANSGENIC ANIMAL
-
批准号:6345909
-
项目类别:
-
资助金额:$22.37万
-
财政年份:2000
-
负责人:MATTHEW P FROSCH
-
依托单位:
Core--Neuropathology of Parkinson's disease and related Lewy body disorders
-
批准号:6341055
-
项目类别:
-
资助金额:$29.46万
-
财政年份:2000
-
负责人:MATTHEW P FROSCH
-
依托单位:
CORE--TRANSGENIC ANIMAL
-
批准号:6201072
-
项目类别:
-
资助金额:$22.37万
-
财政年份:1999
-
负责人:MATTHEW P FROSCH
-
依托单位:
Core--Neuropathology of Parkinson's disease and related Lewy body disorders
-
批准号:6302895
-
项目类别:
-
资助金额:$29.46万
-
财政年份:1999
-
负责人:MATTHEW P FROSCH
-
依托单位:
Core--Neuropathology of Parkinson's disease and related Lewy body disorders
-
批准号:6259569
-
项目类别:
-
资助金额:$29.46万
-
财政年份:1999
-
负责人:MATTHEW P FROSCH
-
依托单位:
CORE--TRANSGENIC ANIMAL
-
批准号:6098805
-
项目类别:
-
资助金额:$22.37万
-
财政年份:1998
-
负责人:MATTHEW P FROSCH
-
依托单位:
PRESENILIN 1 TRANSGENIC MICE--ALZHEIMER DISEASE MODELS
-
批准号:2408471
-
项目类别:
-
资助金额:$6.31万
-
财政年份:1997
-
负责人:MATTHEW P FROSCH
-
依托单位:
NOVEL ENDOTHELIAL CELL CADHERIN LIKE MOLECULE
-
批准号:2211258
-
项目类别:
-
资助金额:$8.69万
-
财政年份:1994
-
负责人:MATTHEW P FROSCH
-
依托单位:
海外基金